Aemetis (NASDAQ:AMTX – Get Free Report) released its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.18, FiscalAI reports. The firm had revenue of $88.15 million for the quarter, compared to analyst estimates of $74.20 million.
Here are the key takeaways from Aemetis’ conference call:
- Third-quarter results improved sharply: revenue rose 49% year over year to $88.2 million, net income was $5.2 million, and Adjusted EBITDA reached $24.8 million, versus a loss in both measures a year earlier. Results included $24.7 million in 45Z tax-credit revenue, including an $11 million catch-up adjustment, so reported performance was partly driven by credits.
- Aemetis said seven dairy RNG pathways averaging a carbon-intensity score of negative 380 are approved, with six more pending, supporting greater LCFS credit generation. The company also reported 14 operating digesters and said production has exceeded its forecasts, though further growth depends in part on new pathway approvals and financing.
- The Keyes ethanol plant’s MVR project is expected by management to add about $32 million in annual cash flow through lower natural-gas use and higher-value credits. Construction is progressing, but completion is targeted for the first half of 2027 and management expects most financial benefits in the second half, subject to commissioning.
- Quarter-end cash was $3.4 million after $20.2 million of quarterly capital investment; the company also received $22.4 million from selling 45Z credits. A biogas preferred-unit redemption date was extended to December 31, 2026, highlighting ongoing funding and liquidity considerations.
- India biodiesel sales rebounded to $7.3 million as deliveries resumed under a $17 million allocation, and the company expects export approvals for Europe in the fourth quarter. Management cited potential access to its 80-million-gallon capacity, but noted practical supply-chain limits and did not expect long-term offtake contracts.
Aemetis Trading Down 1.4%
AMTX traded down $0.03 on Friday, hitting $1.71. The company had a trading volume of 1,645,095 shares, compared to its average volume of 1,265,422. The firm has a market cap of $123.05 million, a P/E ratio of -1.87 and a beta of 1.87. Aemetis has a 1 year low of $1.11 and a 1 year high of $3.80. The company’s fifty day moving average price is $1.67 and its 200 day moving average price is $1.94.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on AMTX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Thursday, October 15th. Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a research report on Saturday, August 22nd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $11.88.
Read Our Latest Stock Analysis on AMTX
More Aemetis News
Here are the key news stories impacting Aemetis this week:
- Positive Sentiment: Q3 revenue rose 49% year over year to $88.2 million, while Aemetis reported $5.2 million in net income and $24.8 million in adjusted EBITDA. The reported per-share loss of $0.02 was also better than the $0.20 loss analysts expected. Aemetis Q3 2026 financial results
- Positive Sentiment: Biogas renewable natural gas sales volume increased 39% to 158,200 MMBtu. Two digesters began operating in October, expanding the network to 14 digesters and supporting the company’s growth plans. Aemetis Q3 2026 financial results
- Positive Sentiment: Aemetis expects its MVR project to contribute $32 million in annual cash flow in 2027, and said higher 45Z credit values could improve the economics of its renewable fuel operations. Aemetis MVR and 45Z outlook
- Neutral Sentiment: The quarter included $24.7 million in 45Z production tax credit income, including an approximately $11 million adjustment for the first half of 2026. This boosted results, but makes performance partly dependent on tax-credit rules and continued project execution. Aemetis Q3 2026 financial results
Aemetis Company Profile
Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.
The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.
Featured Articles
- Five stocks we like better than Aemetis
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
- Arista Networks Cashes In on the AI Infrastructure Buildout
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
